Silvia Mari, PhD
Lugano, Switzerland
Silvia Mari, embarked on her academic journey with a Master's Degree in Industrial Chemistry from the University of Milan, followed by a PhD in Chemistry from Universidad Autonoma de Madrid, and a postdoc research activities at San Raffaele University Hospital of Milan. She is author of 23 publications and significant collaborations in drug optimization and metabolomics, and registered expert of the European Commission.
Her transition to project management was marked by a Certificate in Advanced Studies in Management of Biotech, Medtech & Pharma Ventures from EPFL, Lausanne, subsequently by a Certificate in Advanced Studies in Project Management from SUPSI, Lugano, and finally by PMP certification by Project Management Institute. This laid the groundwork for her pivotal role in project management, orchestrating the management of projects across international boundaries.
She is currently Senior Lecturer for the Lifelong Learning department at SUPSI in Lugano. She is member of PMI and its Swiss Chapter; and she is the treasurer of the local Project Management Association based in Lugano.
In her dynamic career spanning diverse fields and roles such as PMO and Business Agility in manufacturing industry, in compliance, regulatory affairs, and clinical support, where she streamlined operational processes and undertook project management in software development and data integrity. In her capacity as a Software Platform Project Manager, Silvia championed agile methodologies, implementing design thinking to foster innovation in software development. As an Account Manager and Product Manager, Silvia excelled in product management and personalized customer solutions. This included being the driving force behind customer training programs, showcasing her ability to bridge technical expertise with effective communication, and a core belief in the power of collaboration, adaptability, and strategic thinking.
Silvia can be contacted at mailto:mari.silvia.sciortino@gmail.com
Profile created 11 January 2024
